(S (NP-SBJ (DT The) (JJ Epstein-Barr) (NN virus) (JJ nuclear) (NN antigen) (CD 2)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT an) (ADJP (NN EBNA2) (JJ responsive)) (NN cis-element)) (PP (IN of) (NP (DT the) (JJ terminal) (NN protein) (CD 1) (NN gene) (NN promoter)))))) (. .))
(S (NP-SBJ (DT The) (JJ Epstein-Barr) (NN virus) (NN protein) (NN EBNA2)) (VP-COOD (VP (VBZ acts) (PP (IN as) (NP (NP (DT a) (JJ transcriptional) (NN activator)) (PP (IN of) (NP (ADJP-COOD (ADJP (JJ cellular)) (CC and) (ADJP (JJ viral))) (NNS genes)))))) (CC and) (VP (VBZ plays) (NP (DT a) (JJ crucial) (NN role)) (PP (IN in) (NP (NP (DT the) (NN immortalization)) (PP (IN of) (NP (JJ human) (JJ primary) (NNS B-cells))) (PP (IN by) (NP (NN EBV))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN shown) (ADVP-TMP (RB previously)) (SBAR (IN that) (S (NP-SBJ (NN EBNA2)) (VP (VBZ transactivates) (NP (NP (DT the) (NNS promoters)) (PP (IN of) (NP (DT the) (JJ latent) (NN membrane) (NNS antigens) (NP-COOD (NP (NN LMP)) (, ,) (NP (NN TP1)) (CC and) (NP (NN TP2))))))))))) (. .))
(S (NP-SBJ-60 (NP (DT The) (NN promoter)) (PP (IN of) (NP (DT the) (NN TP1) (NN gene)))) (VP (VBD was) (VP (VBN chosen) (NP (-NONE- *-60)) (PP (IN as) (NP (NP (DT a) (JJ model) (NN system)) (SBAR (WHADVP-104 (-NONE- 0)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB study) (NP (NP (DT the) (JJ molecular) (NN mechanism)) (PP (IN of) (NP (ADJP (NN EBNA2) (JJ mediated)) (NN transactivation)))) (ADVP (-NONE- *T*-104)))))))))) (. .))
(S (S (NP-SBJ (-NONE- *)) (VP (TO To) (VP (VB identify) (NP (DT an) (ADJP (NN EBNA2) (JJ dependent)) (JJ cis-acting) (NN element))))) (, ,) (NP-SBJ-61 (JJ various) (NN TP1) (NN promoter-reporter) (NN gene) (NNS constructs)) (VP (VBD were) (VP (VBN transfected) (NP (-NONE- *-61)) (PP (IN in) (NP (NP (DT the) (NP-COOD (NP (NN absence)) (CC and) (NP (NN presence)))) (PP (IN of) (NP (DT an) (NN EBNA2) (NN expression) (NN vector))))) (PP (IN into) (NP (DT the) (JJ established) (NN B-cell) (NN line) (NN BL41-P3HR1))))) (. .))
(S (NP-SBJ-62 (PRP We)) (VP (VBD were) (ADJP-PRD (JJ able) (S (NP-SBJ (-NONE- *-62)) (VP (TO to) (VP (VB delineate) (NP (NP (DT an) (CD 81) (NN bp) (ADJP (NN EBNA2) (JJ responsive)) (NN region)) (PP (IN between) (NP (NP-COOD (NP (CD -258)) (CC and) (NP (CD -177))) (PP (JJ relative) (TO to) (NP (DT the) (NN TP1) (NN RNA) (NN start) (NN site))))))))))) (. .))
(S (NP-SBJ (DT The) (NN element)) (VP-COOD (VP (VBD worked) (PP (IN in) (NP (DT either) (NN orientation)))) (CC and) (VP (MD could) (VP (VB mediate) (NP (NP (ADJP (NN EBNA2) (JJ dependent)) (NN transactivation)) (PP (IN on) (NP (DT a) (JJ heterologous) (NN promoter))))))) (. .))
(S (NP-SBJ (JJ Electrophoretic) (NN mobility) (NN shift) (NNS assays)) (VP (VBD revealed) (NP (NP (CD three) (JJ specific) (NN protein-DNA) (NNS complexes)) (VP (VBN formed) (NP (-NONE- *)) (PP (IN with) (NP (NP (NNS sequences)) (PP (IN of) (NP (DT the) (ADJP (NN EBNA2) (JJ responsive)) (NN element)))))))) (. .))
(S-COOD (S (NP-SBJ (NP (CD Two)) (PP (IN of) (NP (DT these)))) (VP (VBD were) (RB not) (ADJP-PRD (NP (NN cell) (NN type)) (JJ specific)))) (, ,) (CC but) (S (NP-SBJ-65 (DT the) (JJ third)) (VP (VBD was) (VP (VBN detected) (NP (-NONE- *-65)) (PP (RB only) (IN in) (NP (ADJP (NN EBNA2) (JJ positive)) (NN cell) (NNS extracts)))))) (. .))
(S (NP-SBJ (NP (JJ Gel-shift) (NN analysis)) (PP (IN in) (DT the) (NN presence) (IN of) (NP (ADJP (NN EBNA2) (JJ specific)) (JJ monoclonal) (NNS antibodies)))) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ (NN EBNA2)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN component)) (PP (IN of) (NP (DT the) (JJ third) (NN complex)))))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP-SBJ (DT these) (NNS experiments)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NN EBNA2)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT an) (ADJP (NN EBNA2) (JJ responsive)) (NN cis-element)) (PP (IN of) (NP (DT the) (NN TP1) (NN promoter))))))))) (. .))
